Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microenvironment in pancreatic cancer: a retrospective cohort study
Authors:
- Jing LiJLJing Li
- Jiayi WangJWJiayi Wang
- Yuxuan LiYLYuxuan Li
- Wenna JiangWJWenna Jiang
- Duo ZuoDZDuo Zuo
- Xiuse ZhangXZXiuse Zhang
- Jiawei XiaoJXJiawei Xiao
- Kentaro InamuraKIKentaro Inamura
- Elisa GiovannettiEGElisa Giovannetti
- Li RenLRLi Ren
Open Access
- 1 June 2025
- journal article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 16 (3) , 1248-1257
Abstract
Background: An elevated peripheral blood neutrophil-to-lymphocyte ratio (NLR) has been reported to be a negative prognostic marker in many types of cancer, including pancreatic ductal adenocarcinoma (PDAC). However, whether NLR is associated with the tumor-immune microenvironment (TIME) in PDAC is unclear. Understanding the interplay between systemic inflammation as reflected by NLR and TIME in PDAC is crucial for identifying prognostic biomarkers and potential therapeutic targets. The aim of this study was to examine the relationship between the NLR and clinical outcomes in patients with early-stage PDAC and the impact of the TIME in PDAC. Methods: We conducted a retrospective analysis including two cohorts: PDAC patients versus healthy controls and untreated stage I–II PDAC cases. We collected clinical data, including NLR values and followed PDAC patients for overall survival (OS) and relapse-free survival (RFS), and the TIME was evaluated through immunohistochemical staining for CD8+ T cells and CD33+ myeloid-derived suppressor cells (MDSCs). Statistical analyses were performed to assess the relationship between NLR, clinical outcomes, and TIME components to further determine the value of NLR in reflecting the status of the TIME and predicting outcomes of patients with PDAC. Results: NLR was negatively associated with OS and RFS in patients with PDAC. Moreover, NLR was found to be a prognostic factor for PDAC and early-stage PDAC. The NLR was inversely correlated with the abundance of tumoral CD8+ T cells (r=−0.345, P=0.004) and positively correlated with that of CD33+ MDSCs (r=0.407, P=0.001). Conclusions: Our findings indicate that a high NLR value is closely correlated with poor outcomes in patients with PDAC. In addition, it was significantly associated with the presence of tumoral CD8+ tumor-infiltrating lymphocytes and CD33+ cells in the TIME of patients with PDAC. NLR may be a biomarker that can inform treat-related decision-making.Keywords
This publication has 36 references indexed in Scilit:
- Tumor microenvironment: Sanctuary of the devilCancer Letters, 2015
- The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomasInternational Journal of Cancer, 2013
- Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progressionCancer Immunology, Immunotherapy, 2013
- Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancerBritish Journal of Cancer, 2013
- Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapyCancer Immunology, Immunotherapy, 2012
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppressionSeminars in Cancer Biology, 2012
- Accessories to the Crime: Functions of Cells Recruited to the Tumor MicroenvironmentCancer Cell, 2012
- Neutrophil Degranulation and Immunosuppression in Patients with GBM: Restoration of Cellular Immune Function by Targeting Arginase IClinical Cancer Research, 2011
- Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progressionProceedings of the National Academy of Sciences, 2008
- Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesisProceedings of the National Academy of Sciences, 2006